HF 383 would remove the pharmaceutical form of psilocybin (specifically crystalline polymorph COMP 360) from Iowa's Schedule I controlled substances list once the U.S. Food and Drug Administration (FDA) approves it and reschedules it under federal law. This would allow doctors to legally prescribe, distribute, and market COMP 360 for medical use, directly affecting healthcare providers and patients seeking this treatment. The bill automatically aligns Iowa law with federal FDA decisions on this specific pharmaceutical formulation. Note: The bill was vetoed by the governor on June 11, 2025, so it has not become law.
SF 288 requires public colleges and universities governed by the Board of Regents and community colleges to provide academic accommodations for students who are pregnant or who recently gave birth. The law specifically allows these students to withdraw from courses without academic penalty if pregnancy or childbirth prevents them from continuing their studies. Institutions must also provide clear information about available support services, including health care and childcare resources. This policy directly affects pregnant and postpartum students enrolled at these specific public higher education institutions.
HF 303 modifies rules for insurance company approvals (prior authorization) and the organizations that review medical treatment requests (utilization review organizations). It directly affects healthcare providers, insurers, and patients by changing how prior authorization requests are processed. The bill establishes specific timeframes for reviews and requires utilization review organizations to follow standardized procedures. This aims to reduce delays in patient care while maintaining oversight of treatment appropriateness. The legislation passed unanimously and was signed into law by the Governor on May 27, 2025.
HF 300 creates a multi-state agreement (compact) allowing physician assistants licensed in one participating state to practice in other compact states without needing separate licenses. It directly affects physician assistants seeking to work across state lines and healthcare facilities in participating states. The key provision establishes a standardized licensing process where a license issued by one compact state is recognized by all others in the agreement. This reduces administrative barriers for physician assistants and expands their ability to provide care in multiple states without reapplying for licenses. The bill was signed into law by the Governor on May 27, 2025.
This bill updates laws concerning services and support for youth under 21, especially those involved in involuntary commitment, juvenile delinquency, or child and family in need of assistance proceedings. It revises regulations for psychiatric medical institutions for children (PMICs), updating definitions and requiring them to provide comprehensive care that includes physical assessments and behavioral health evaluations. The bill also addresses the licensing and certification of other residential facilities, the provision of home and community-based services to youth, and the administration of juvenile court services. Finally, it modifies Hawki eligibility for inmates of public institutions.
This bill expands Iowa's "Right to Try" Act by broadening the definition of an "eligible patient." Previously limited to individuals with terminal illnesses, the bill now includes patients with life-threatening or severely debilitating illnesses. These patients can access "individualized investigational treatments," which are drugs or products unique to their genetic profile and have successfully completed Phase 1 clinical trials. The bill also defines "eligible facilities" and updates the specific requirements for written informed consent for patients with terminal illnesses.
This bill updates state law by expanding the definition of a "peer review committee." It specifically includes statewide nonprofit organ procurement organizations (OPOs) within this definition. This change grants OPOs the same legal status and protections typically afforded to other peer review committees, such as those in hospitals or medical societies. The bill directly affects organ procurement organizations operating in the state by formally recognizing their internal review processes under this designation.
SF 315, known as the "Iowa Competitive Pharmacy Benefits Managers Marketplace Act," aims to reduce prescription drug costs for public employees in self-funded state health plans. The bill mandates that the state department procure pharmacy benefits manager (PBM) services through a "reverse auction" process. This online, competitive bidding system allows PBMs to offer progressively lower prices for their services. Additionally, the department must acquire a technology platform to conduct these auctions and perform detailed, line-by-line audits of PBM claims to ensure contract compliance. The first PBM contract awarded through this new system is scheduled to take effect on January 1, 2026.
This bill modifies Iowa's existing law concerning school concussion and brain injury policies. It specifically expands the definition of "licensed health care provider" for the purpose of clearing students to return to extracurricular interscholastic activities after experiencing a concussion or brain injury. Under this bill, a person who holds a doctorate in psychology with specialty training in neuropsychology or concussion management would be added to the list of professionals who can provide such clearance. This change directly affects students participating in school activities and the range of medical professionals involved in their return-to-play protocols.
House File 875 modifies the credentialing process for health insurers and certain healthcare providers. The bill requires health insurers to respond to credentialing requests from physicians, advanced registered nurse practitioners, and physician assistants within 56 calendar days. If a health insurer denies a credentialing request, it must provide the applicant with a written reason for the denial. These changes aim to improve the transparency and efficiency of the process by which these medical professionals become authorized to provide services and receive payment through health insurance plans.